A jogsértések akkor is előfordulhatnak, ha: • Nincs tisztességtelen szándék. • A kifizetést, ajándékot vagy vendéglátást csak felajánlják vagy megígérik, de arra ténylegesen nem kerül sor. • A kifizetésre sor kerül, de nem érik el vele a kívánt eredményt. • Az eredményből más húz hasznot, nem az, aki adja (például üzleti előny átirányítása egy harmadik félnek). • Az illető személy javasolta vagy követelte a kenőpénzt. • A vállalat úgy véli, hogy már jogosult az intézkedésre vagy előnyre. • Egy személynek „tudnia kellett volna”, hogy vesztegetés történt. Egy kormányhivatalnok azonosítása legtöbbször egyértelmű, de nem mindig. A munkatársak soha nem ajánlhatnak fel el értékkel bíró dolgot létező vagy potenciális ügyfeleknek, beszállítóknak vagy egyéb harmadik feleknek, illetve nem fogadhatnak el tőlük annak érdekében, hogy jogtalan üzlethez vagy tisztességtelen előnyhöz juttassa az Avientet.

Purchase price multiple rapidly declining on strength of business and synergy capture (1) (1) (1) Financial information is pro forma to include a full year of Clariant Color acquisition ($ in millions) 11.9% 16.3% 2019PF 2021E EBITDA Margins (1) Avient Corporation 12 People C U L T U R E I S E V E R Y T H I N G Avient Corporation 13 Community Service 7x Safer than Industry Average World-Class Safety Leadership Development Over $16 million raised since 2010 Diversity & Inclusion Future Growth in Excess of GDP is Driven By: Our company is positioned to sustainably grow at a rate that exceeds GDP. D is t. ) K W R P P G A V Y F U L R P M G C P F M C H X L H U N E C L E M N C E A S H S C L Source: Peer data per Bloomberg market data as of December 2, 2021 Avient reflects 2021 estimated revenue of $4,750M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) 129Avient Corporation 474 644 1,002 107 147 216 467 616 872 2014 2018 2021E R&D / Technical Marketing Sales Commercial Resources Headcount figures all Pro Forma for sale of Designed Structures and Solutions (DSS) and Performance Products and Solutions (PP&S) segments. 2021E data as of October 31, 2021. Avient is High Touch Avient Corporation 130 86 93 85 82 79 77 74 89 85 82 81 79 78 77 74 72 25 A vi en t K W R P P G A V Y F U L R P M G C P F M C U N V R C E B N R H X L E C L E M N H U N A S H S C L 2021E (%) 1.

Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022. To provide comparable results, the company references “pro forma” financial metrics, which include the business results of Avient Protective Materials for periods prior to the Acquisition Date, as if the transaction occurred on January 1, 2021 and reflect Distribution as a discontinued operation. Three Months Ended March 31, 2023 Three Months Ended March 31, 2022 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net income from continuing operations attributable to Avient shareholders $ 20.8 $ 0.23 $ 64.4 $ 0.70 Special items, after tax 22.3 0.24 6.4 0.07 Amortization expense, after-tax 15.1 0.16 $ 10.8 $ 0.12 Adjusted net income / EPS $ 58.2 $ 0.63 $ 81.6 $ 0.89 Three Months Ended March 31, Reconciliation of Pro Forma Sales 2023 2022 Sales $ 845.7 $ 892.2 APM pro forma adjustments — 94.9 Pro forma sales $ 845.7 $ 987.1 1 Three Months Ended March 31, Reconciliation to EBITDA and Adjusted EBITDA: 2023 2022 Net income from continuing operations – GAAP $ 21.3 $ 64.7 Income tax expense 7.7 20.0 Interest expense, net 28.8 16.9 Depreciation and amortization 50.5 37.6 EBITDA from continuing operations $ 108.3 $ 139.2 Special items, before tax 27.3 6.7 Depreciation and amortization included in special items (1.8) (2.1) Adjusted EBITDA $ 133.8 $ 143.8 Pro forma APM adjustments — 32.0 Pro forma adjusted EBITDA $ 133.8 $ 175.8 Pro forma adjusted EBITDA as a % of sales 15.8 % 17.8 % Three Months Ended March 31, 2023 2022 Sales: Color, Additives and Inks $ 537.0 $ 649.5 Specialty Engineered Materials 309.7 243.1 Corporate (1.0) (0.4) Sales $ 845.7 $ 892.2 Operating income: Color, Additives and Inks $ 65.6 $ 94.5 Specialty Engineered Materials 43.1 38.3 Corporate (51.6) (30.6) Operating income $ 57.1 $ 102.2 Depreciation & amortization: Color, Additives and Inks $ 25.8 $ 26.0 Specialty Engineered Materials 21.2 7.8 Corporate 3.5 3.8 Depreciation & Amortization $ 50.5 $ 37.6 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 91.4 $ 120.5 Specialty Engineered Materials 64.3 46.1 Corporate (48.1) (26.8) Other income (expense), net 0.7 (0.6) EBITDA $ 108.3 $ 139.2 2 AVNT Q1 2023 Earnings Presentation v2 AVNT Q1 2023 Earnings Presentation 5.2 221pm IR Deck - AVNT-2023.03.31 (002).pdf

Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022. GUIDANCE (TOTAL COMPANY PRO FORMA) 7 $100 $107 Guidance Pro Forma $0.33 $0.42 Guidance Pro Forma Adjusted EBITDA Adjusted EPS (in millions) $200 $293 Guidance Actual Free Cash Flow (in millions) FY 2022 VS. EBITDA Margins (1) 5.4% 11.5% 16.2% 2006 2018 2022PF $142 $408 $592 2006 2018 2022PF 2006 figures exclude joint venture results 2022 pro forma for the acquisition of Avient Protective Materials Adj.

D is t. ) K W R P P G F U L R P M A V Y F M C H U N H X L S C L E C L E M N C E A S H Source: Peer data per Bloomberg market data as of February 15, 2022. OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 5.4 8.5 10.1 10.0 15.7 15.0 14.2 12.7 10.2 25.0 19.7 17.7 13.2 12.3 10.0 9.9 8.9 8.5 8.3 6.6 A vi en t (2 01 1) A vi en t (2 01 6) A vi en t (2 02 1) A vi en t (T o da y) R P M K W R P P G A V Y F U L A L B E C L H X L A S H F M C B N R E M N U N V R C E S C L H U N Historic Multiple SUMMARY: WHY INVEST IN AVIENT? To provide comparable financial results, the Company references “pro forma” financial metrics, which include the business results of CMB for periods prior to the Acquisition Date.

To provide comparable financial results, the Company references “pro forma” financial metrics, which include the business results of CMB for periods prior to the Acquisition Date. This innovation drives performance and is reflective of consistent, strategic investments in our portfolio…and people. 2020 Pro forma $991 $86 Sustainable Solutions 15 11% 6 Healthcare 28 22% 6 Composites 6 10% 3 Growth in Emerging Regions 44 30% 10 Other 53 10% 7 Sub-total $1,137 15% $118 FX Impact 25 - 2 Synergies - - 11 Incentives, Travel, Other Employee Costs - - (8) 2021 Actual $1,162 17% $123 Q1 2021 ORGANIC SALES AND OPERATING INCOME (TOTAL COMPANY) 18 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Sales Growth Rate Adjusted Operating Income$ millions (1) 19 Electrical & Electronics Building & Construction Wire & Cable Transportation Industrial Healthcare Packaging Consumer Q1 2020PF Q1 2021 (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (2) Financial information is presented on a constant currency basis (1,2) (42% of total revenue) (58% of total revenue) Q1 END MARKET SALES PERFORMANCE +17% +14% +8% +10% +8% +22% +5% +24% Q 2 AN D FU LL Y EA R 2021 O U TLO O K $69 $112 2020PF 2021E $0.42 $0.80 2020PF 2021E ORGANIC GROWTH PROJECTIONS – Q2 (TOTAL COMPANY) 21 Sales Adjusted Operating Income $870 $1,100 2020PF 2021E + 26% Adjusted EPS + 62% + 90% (in millions) (in millions) (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition FULL YEAR GUIDANCE INCREASED 22 Sales Adj. D is t. ) K W R R P M P P G A V Y F U L G C P IF F H X L F M C F O E H U N E C L K R A E M N A S H C E S C L G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of April 27, 2021 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.

NYSE: AVNT) AVIENT CORPORATION S P E C I A LT Y P O R T F O L I O T R A N S F O R M AT I O N C O N T I N U E S W I T H D Y N E E M A A C Q U I S I T I O N 2 0 2 2 F I R S T Q U A R T E R R E S U LT S DISCLAIMER 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Avient also references “pro forma” financial metrics, which include the results of the proposed Dyneema acquisition. Avient pro forma reflects 2022 estimated EBITDA of $660M and revenue of $3,740M.

Purchase price multiple rapidly declining on strength of business and synergy capture 12 $133 $201 2019PF 2022E 12 Clariant Color EBITDA Growth Purchase Price Multiple 10.8x 7.0x 6.4x 2019PF 2021 2022E w/ Full Synergies (1) (1) 11.9% 16.3% 2019PF 2022E EBITDA Margins (1) CLARIANT COLOR: TRANSFORMATIONAL ACQUISITION ($ in millions) (1) Financial information is pro forma to include a full year of Clariant Color business SUNBELT PVC Resins DSS 20 Acquisitions $4.8B Investment $2.7B of Annual Revenue 5 Divestments $2.3B Proceeds TPE PP&S HISTORIC SPECIALIZATION THROUGH M&A 13 Distribution DSM Protective Materials BOLT-ON ACQUISITION HISTORY 14 Commercial Resources Operating Income ($ in millions) Operating Margins 259 363 At Acquisition 2022E $40 $139 At Acquisition 2022E 9% 22% At Acquisition 2022E Established Acquisitions (> 7 years) + 40% + 248% + 1300 bps I N V E S T T O G R O W SPECIALTY TRANSFORMATION T O D A Y 7% 46% 67% 86% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2019 2021 2022 PF % o f A d ju st ed E B IT D A • Commodity JVs • Distribution • Performance Products & Solutions • Specialty Businesses (1) Adjusted EBITDA is EBITDA excluding corporate costs and special items (2) Pro forma for the acquisition of Dyneema® and divestiture of Distribution (1 ) (2) 15 Healthcare 4% Packaging 8% Consumer 10% Building & Construction 43% Industrial 15% Transportation 14% Energy 4% Telecom. 2% 2006 2022 Pro Forma Healthcare 8% Packaging 23% Consumer 21% Building & Construction 10% Industrial 15% Transportation 9% Energy 4% Telecom. 4% Defense 6% END MARKET FOCUS ON LESS CYCLICAL INDUSTRIES 16 14.8% 17.6% 21.0% 2018 2020 2022 PF 1.8% 2006 15.3% 16.2% 17.0% 2018PF 2020PF 2022E CAI 2.7% 2006 SEM SPECIALTY EBITDA MARGIN EXPANSION 17 • Portfolio transformation accelerates growth in less cyclical, higher margin end markets • Investments in our composites platform continue to drive margin expansion (1) (1) (1) 2018 and 2020 financial information is pro forma to include a full year of Clariant Color acquisition PORTFOLIO EVOLUTION OVER THE YEARS 18 Adj. Ops Pro Forma $2.60 $2.95 Cont. Ops Pro Forma FULL YEAR 2022 GUIDANCE 24 Sales Adjusted EBITDA $3,375 $3,635 Cont.

Purchase price multiple rapidly declining on strength of business and synergy capture 12 $133 $201 2019PF 2022E 12 Clariant Color EBITDA Growth Purchase Price Multiple 10.8x 7.0x 6.4x 2019PF 2021 2022E w/ Full Synergies (1) (1) 11.9% 16.3% 2019PF 2022E EBITDA Margins (1) CLARIANT COLOR: TRANSFORMATIONAL ACQUISITION ($ in millions) (1) Financial information is pro forma to include a full year of Clariant Color business SUNBELT PVC Resins DSS 20 Acquisitions $4.8B Investment $2.7B of Annual Revenue 5 Divestments $2.3B Proceeds TPE PP&S HISTORIC SPECIALIZATION THROUGH M&A 13 Distribution DSM Protective Materials BOLT-ON ACQUISITION HISTORY 14 Commercial Resources Operating Income ($ in millions) Operating Margins 259 363 At Acquisition 2022E $40 $139 At Acquisition 2022E 9% 22% At Acquisition 2022E Established Acquisitions (> 7 years) + 40% + 248% + 1300 bps I N V E S T T O G R O W SPECIALTY TRANSFORMATION T O D A Y 7% 46% 67% 86% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2019 2021 2022 PF % o f A d ju st ed E B IT D A • Commodity JVs • Distribution • Performance Products & Solutions • Specialty Businesses (1) Adjusted EBITDA is EBITDA excluding corporate costs and special items (2) Pro forma for the acquisition of Dyneema® and divestiture of Distribution (1 ) (2) 15 Healthcare 4% Packaging 8% Consumer 10% Building & Construction 43% Industrial 15% Transportation 14% Energy 4% Telecom. 2% 2006 2022 Pro Forma Healthcare 8% Packaging 23% Consumer 21% Building & Construction 10% Industrial 15% Transportation 9% Energy 4% Telecom. 4% Defense 6% END MARKET FOCUS ON LESS CYCLICAL INDUSTRIES 16 14.8% 17.6% 21.0% 2018 2020 2022 PF 1.8% 2006 15.3% 16.2% 17.0% 2018PF 2020PF 2022E CAI 2.7% 2006 SEM SPECIALTY EBITDA MARGIN EXPANSION 17 • Portfolio transformation accelerates growth in less cyclical, higher margin end markets • Investments in our composites platform continue to drive margin expansion (1) (1) (1) 2018 and 2020 financial information is pro forma to include a full year of Clariant Color acquisition PORTFOLIO EVOLUTION OVER THE YEARS 18 Adj. Ops Pro Forma $2.60 $2.95 Cont. Ops Pro Forma FULL YEAR 2022 GUIDANCE 24 Sales Adjusted EBITDA $3,375 $3,635 Cont.

• Factors that could cause actual results to differ materially from those implied by these forward looking statements include but are not limited to:• Factors that could cause actual results to differ materially from those implied by these forward‐looking statements include, but are not limited to:  Our ability to achieve the strategic and other objectives relating to the Spartech acquisition, including any expected synergies; our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The amount and timing of repurchases, if any, of PolyOne common shares and our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;g p y p g ;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;, , p y p y g , y p p ;  An inability to maintain appropriate relations with unions and employees; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation. • The above list of factors is not exhaustive. • We undertake no obligation to publicly update forward‐looking statements, whether as a result of new information, future events or otherwise. In certain cases throughout this presentation, we have presented GAAP and non‐GAAP financial measures adjusted to reflect full‐ year 2012 Pro forma results, including Spartech and Glasforms. • PolyOne’s chief operating decision makers use these financial measures to monitor and evaluate the ongoing performance of the Company and each business segment and to allocate resources. Pro Forma Debt 2012 7.500% debentures due 2015 $ 50.0 7.375% senior notes due 2020 360.0 5.250% senior notes due 2023 600.0 Other debt 14.0 Pro Forma Debt $ 1,024 Specialty Platform Gross Margin Percentage 2006 2012 Global Specialty Engineered Materials Sales $ 345.3 $ 543.6 Global Color, Additives and Inks Sales 531.8 703.5 Specialty Platform Sales $ 877.1 $ 1,247.1 Global Specialty Engineered Materials Gross Margin $ 41.6 $ 129.8 Global Color, Additives and Inks Gross Margin 83.6 220.6 Specialty Platform Gross Margin $ 125.2 $ 350.4 Specialty Platform Gross Margin Percentage 14.3% 28.1%